Long-term outcomes of invasive lobular carcinoma compared with invasive ductal carcinoma in HR-positive/HER2-negative breast cancer: a focus on luminal subtypes
Medicine
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.